Literature DB >> 19448978

Anticancer properties of highly purified L-asparaginase from Withania somnifera L. against acute lymphoblastic leukemia.

Vishal P Oza1, Pritesh P Parmar, Sushil Kumar, R B Subramanian.   

Abstract

Withania somnifera L. has been traditionally used as a sedative and hypnotic. The present study was carried out for the purification, characterization, and in vitro cytotoxicity of L-asparaginase from W. somnifera L. L-Asparaginase was purified from the fruits of W. somnifera L. up to 95% through chromatography. The purified L-asparaginase was characterized by size exclusion chromatography, polyacrylamide gel electrophoresis (PAGE), and 2D PAGE. The antitumor and growth inhibition effect of the L-asparaginase was assessed using [3-(4, 5-dimethyl-thiazol-2yl)-2, 5-diphenyl-tetrazolium bromide] (MTT) colorimetric dye reduction method. The purified enzyme is a homodimer, with a molecular mass of 72 +/- 0.5 kDa, and the pI value of the enzyme was around 5.1. This is the first report of the plant containing L-asparaginase with antitumor activity. Data obtained from the MTT assay showed a LD(50) value of 1.45 +/- 0.05 IU/ml. W. somnifera L. proved to be an effective and a novel source of L: -asparaginase. Furthermore, it shows a lot of similarity with bacterial L-asparaginases EC-2.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19448978     DOI: 10.1007/s12010-009-8667-z

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  9 in total

1.  Structural analysis of K+ dependence in L-asparaginases from Lotus japonicus.

Authors:  Alfredo Credali; Antonio Díaz-Quintana; Margarita García-Calderón; Miguel A De la Rosa; Antonio J Márquez; José M Vega
Journal:  Planta       Date:  2011-03-10       Impact factor: 4.116

2.  Cloning, expression and characterization of l-asparaginase from Withania somnifera L. for large scale production.

Authors:  Vishal P Oza; Pritesh P Parmar; Darshan H Patel; R B Subramanian
Journal:  3 Biotech       Date:  2011-04-07       Impact factor: 2.406

3.  Bioprocess Optimization of Nutritional Parameters for Enhanced Anti-leukemic L-Asparaginase Production by Aspergillus candidus UCCM 00117: A Sequential Statistical Approach.

Authors:  Maurice Ekpenyong; Atim Asitok; Richard Antigha; Nkpa Ogarekpe; Ubong Ekong; Marcus Asuquo; Joseph Essien; Sylvester Antai
Journal:  Int J Pept Res Ther       Date:  2021-03-09       Impact factor: 1.931

4.  Anticancer L-Asparaginase and Phytoactive Compounds From Plant Solanum nigrum Against MDR (Methicillindrug resistant) Staphylococcus aureus and Fungal Isolates.

Authors:  Ambreen Aisha; Saba Zahra; Imtiaz M Tahir; Asim Hussain; Naheed Bano; Alishbah Roobi; Nadia Afsheen; Yasir Saleem
Journal:  Dose Response       Date:  2022-04-27       Impact factor: 2.623

Review 5.  The Updated Review on Plant Peptides and Their Applications in Human Health.

Authors:  Saiprahalad Mani; Smruti B Bhatt; Vinduja Vasudevan; Dhamodharan Prabhu; Sundararaj Rajamanikandan; Palaniyandi Velusamy; Palaniappan Ramasamy; Pachaiappan Raman
Journal:  Int J Pept Res Ther       Date:  2022-07-27       Impact factor: 2.191

6.  Purification and Characterization of Asparaginase from Phaseolus vulgaris Seeds.

Authors:  Saleh A Mohamed; Mohamed F Elshal; Taha A Kumosani; Alia M Aldahlawi
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-27       Impact factor: 2.629

7.  Withania somnifera Induces Cytotoxic and Cytostatic Effects on Human T Leukemia Cells.

Authors:  Eleonora Turrini; Cinzia Calcabrini; Piero Sestili; Elena Catanzaro; Elena de Gianni; Anna Rita Diaz; Patrizia Hrelia; Massimo Tacchini; Alessandra Guerrini; Barbara Canonico; Stefano Papa; Giovanni Valdrè; Carmela Fimognari
Journal:  Toxins (Basel)       Date:  2016-05-12       Impact factor: 4.546

Review 8.  Anticancer Activity of Bacterial Proteins and Peptides.

Authors:  Tomasz M Karpiński; Artur Adamczak
Journal:  Pharmaceutics       Date:  2018-04-30       Impact factor: 6.321

Review 9.  Withania somnifera: Progress towards a Pharmaceutical Agent for Immunomodulation and Cancer Therapeutics.

Authors:  Vivek K Kashyap; Godwin Peasah-Darkwah; Anupam Dhasmana; Meena Jaggi; Murali M Yallapu; Subhash C Chauhan
Journal:  Pharmaceutics       Date:  2022-03-10       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.